Lista de obras - Jitka Palich Fučíková

Apoptotic caspases cut down the immunogenicity of radiation

artículo científico publicado en 2019

Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients

scientific article published on 26 August 2019

Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood

scientific article published on 27 June 2019

Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

artículo científico publicado en 2016

Calreticulin and cancer

artículo científico publicado en 2020

Calreticulin arms NK cells against leukemia

artículo científico publicado en 2019

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

artículo científico publicado en 2016

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

artículo científico publicado en 2019

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients

artículo científico publicado en 2019

Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death.

artículo científico publicado en 2016

Classification of current anticancer immunotherapies

artículo científico publicado en 2014

Combinatorial strategies for the induction of immunogenic cell death

artículo científico publicado en 2015

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

scientific article published on 01 March 2020

Consensus guidelines for the detection of immunogenic cell death

artículo científico publicado en 2014

Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade

artículo científico publicado en 2020

Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death".

artículo científico publicado en 2015

Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs

artículo científico publicado en 2014

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy.

artículo científico publicado en 2015

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice

artículo científico publicado en 2017

Detection of immunogenic cell death and its relevance for cancer therapy

artículo científico publicado en 2020

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma

artículo científico publicado en 2015

Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells

artículo científico publicado en 2012

Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.

artículo científico publicado en 2012

High hydrostatic pressure induces immunogenic cell death in human tumor cells

artículo científico publicado en 2014

Human tumor cells killed by anthracyclines induce a tumor-specific immune response

artículo científico publicado en 2011

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 30 July 2020

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

artículo científico publicado en 2019

Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy ⬇️

artículo científico publicado el 26 de agosto de 2012

M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer

scientific article published on 01 August 2020

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients

artículo científico publicado en 2018

Methods to assess DC-dependent priming of T cell responses by dying cells

artículo científico publicado en 2019

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

artículo científico publicado en 2015

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer

artículo científico publicado en 2015

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.

artículo científico publicado en 2017

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy

artículo científico publicado en 2014

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials ⬇️

artículo científico publicado el 30 de diciembre de 2011

Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer

artículo científico publicado en 2015

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

scientific article published on 17 September 2020

Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents.

artículo científico publicado en 2016

Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer

artículo científico publicado en 2017

Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death

artículo científico publicado en 2019

TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer

artículo científico publicado en 2019

Trial Watch-Immunostimulation with cytokines in cancer therapy

artículo científico publicado en 2015

Trial Watch-Oncolytic viruses and cancer therapy

artículo científico publicado en 2015

Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy

artículo científico publicado en 2016

Trial Watch: Adoptive cell transfer for oncological indications

artículo científico publicado en 2015

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

artículo científico publicado en 2015

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

artículo científico publicado en 2015

Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy

artículo científico publicado en 2015

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

scholarly article by Elena García-Martínez et al published 2018 in OncoImmunology

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

artículo científico publicado en 2016

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

artículo científico publicado en 2018

Trial Watch: Toll-like receptor agonists in cancer immunotherapy

artículo científico publicado en 2018

Trial watch: Dendritic cell-based anticancer therapy

artículo científico publicado en 2014

Trial watch: Dendritic cell-based interventions for cancer therapy

artículo científico publicado en 2013

Trial watch: Immune checkpoint blockers for cancer therapy

artículo científico publicado en 2017

Trial watch: Naked and vectored DNA-based anticancer vaccines

artículo científico publicado en 2015

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

artículo científico publicado en 2020

Trial watch: peptide-based vaccines in anticancer therapy

artículo científico publicado en 2018

Lista de obras de Jitka Palich Fučíková

Apoptotic caspases cut down the immunogenicity of radiation

Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients

Assessment of NK cell-mediated cytotoxicity by flow cytometry after rapid, high-yield isolation from peripheral blood

Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis

Calreticulin and cancer

Calreticulin arms NK cells against leukemia

Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients

Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients

Caspase-2 and oxidative stress underlie the immunogenic potential of high hydrostatic pressure-induced cancer cell death.

Classification of current anticancer immunotherapies

Combinatorial strategies for the induction of immunogenic cell death

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

Consensus guidelines for the detection of immunogenic cell death

Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade

Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death".

Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy.

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice

Detection of immunogenic cell death and its relevance for cancer therapy

Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to non-virally induced head and neck squamous cell carcinoma

Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells

Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.

High hydrostatic pressure induces immunogenic cell death in human tumor cells

Human tumor cells killed by anthracyclines induce a tumor-specific immune response

Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications

Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy ⬇️

M2-like macrophages dictate clinically relevant immunosuppression in metastatic ovarian cancer

Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients

Methods to assess DC-dependent priming of T cell responses by dying cells

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.

Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials ⬇️

Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer

Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer

Rationale for the Combination of Dendritic Cell-Based Vaccination Approaches With Chemotherapy Agents.

Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer

Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death

TIM-3 Dictates Functional Orientation of the Immune Infiltrate in Ovarian Cancer

Trial Watch-Immunostimulation with cytokines in cancer therapy

Trial Watch-Oncolytic viruses and cancer therapy

Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy

Trial Watch: Adoptive cell transfer for oncological indications

Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications

Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy

Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

Trial Watch: Toll-like receptor agonists in cancer immunotherapy

Trial watch: Dendritic cell-based anticancer therapy

Trial watch: Dendritic cell-based interventions for cancer therapy

Trial watch: Immune checkpoint blockers for cancer therapy

Trial watch: Naked and vectored DNA-based anticancer vaccines

Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology

Trial watch: peptide-based vaccines in anticancer therapy